These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28841817)

  • 1. Plasma osteopontin concentration is elevated in patients with coronary bare metal stent restenosis.
    Yilmaz KC; Bal UA; Karacaglar E; Okyay K; Aydinalp A; Yildirir A; Muderrisoglu H
    Acta Cardiol; 2018 Feb; 73(1):69-74. PubMed ID: 28841817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between coronary in-stent restenosis and plasma urotensin II level.
    Yavuz F; Ozer O; Ercan S; Yuce M; Davutoglu V; Alici H; Pusuroglu H; Orkmez M; Kaplan M; Basanalan F; Tarakcioglu M
    Minerva Cardioangiol; 2014 Jun; 62(3):297-303. PubMed ID: 24831766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.
    Ucar FM
    BMC Cardiovasc Disord; 2016 Oct; 16(1):186. PubMed ID: 27716070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of C-reactive protein on in-stent restenosis: a meta-analysis.
    Li JJ; Ren Y; Chen KJ; Yeung AC; Xu B; Ruan XM; Yang YJ; Chen JL; Gao RL
    Tex Heart Inst J; 2010; 37(1):49-57. PubMed ID: 20200627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culprit coronary lesions requiring percutaneous coronary intervention after vascular surgery often arise from in-stent restenosis of bare metal stents.
    Garcia S; Murray ST; Moritz TE; Pierpont G; Goldman S; Larsen GC; Littooy F; Ward HB; McFalls EO
    Ann Vasc Surg; 2010 Jul; 24(5):596-601. PubMed ID: 20579583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
    Hitsumoto T; Takahashi M; Iizuka T; Shirai K
    J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary CT angiography (CCTA) using third-generation dual-source CT for ruling out in-stent restenosis.
    Eckert J; Renczes-Janetzko P; Schmidt M; Magedanz A; Voigtländer T; Schmermund A
    Clin Res Cardiol; 2019 Apr; 108(4):402-410. PubMed ID: 30187179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients.
    Szük T; Fejes Z; Debreceni IB; Kerényi A; Édes I; Kappelmayer J; Nagy B
    Platelets; 2016 Jul; 27(5):410-9. PubMed ID: 26765134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.
    Kim JY; Ko YG; Shim CY; Park S; Hwang KC; Choi D; Jang Y; Chung N; Shim WH; Cho SY
    Am J Cardiol; 2005 Nov; 96(10):1384-8. PubMed ID: 16275183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
    Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
    Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
    Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidation may predict restenosis after coronary balloon angioplasty.
    Imai K; Matsubara T; Kanashiro M; Ichimiya S; Hotta N
    Jpn Circ J; 2001 Jun; 65(6):495-9. PubMed ID: 11407729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.